Advanced Cancer Diagnoses Back to Normal After Pandemic, New Study Finds
A major new report brings much-needed relief to the global cancer community, revealing that advanced cancer diagnoses in the United States—which spiked during the early days of the COVID-19 pandemic—have now returned to levels seen before the global crisis. Published Monday in the journal Cancer, the study offers a broad analysis of U.S. cancer statistics, addressing widespread fears that disruptions to screening during the pandemic would drive a lasting increase in late-stage cancer cases and, ultimately, higher death rates (AP News).